Tamir Fishman Ventures

About

Portfolio · 4

VESSL Therapeutics

Regenerative Medicine for Cardiovascular Diseases

Led ★ 1 round $14.0M committed Latest: 2009-01

Allot

Network Intelligence and Security Solutions

2 rounds $13.5M committed Latest: 2006-07

Native Networks

Optical and Metro Ethernet

1 round $3.0M committed Latest: 2003-10

Sagitta E. S.

Manufacturing Equipment for the Fiber Optics Industry

2 rounds $20.3M committed Latest: 2002-01

Investment activity

2 portfolio exits on record.

Q&A

What is Tamir Fishman Ventures' primary geographic focus?

Tamir Fishman Ventures is based in Tel Aviv-Yafo, Israel, indicating a primary focus on the Israeli market.

When was Tamir Fishman Ventures established?

Tamir Fishman Ventures was established in 2000 by Eldad Tamir and Dani Fishman.

What is the approximate total AUM for Tamir Fishman Ventures?

Tamir Fishman Ventures manages approximately $150 million across its funds.

Can you name a notable exit for Tamir Fishman Ventures?

One notable exit for Tamir Fishman Ventures was Allot, which went public on NASDAQ in November 2006 with a valuation of $250 million.

Which company did Tamir Fishman Ventures exit through an acquisition?

Tamir Fishman Ventures exited Native Networks through an acquisition by Alcatel-Lucent in March 2005 for $55 million.

Who are the founders of Tamir Fishman Ventures?

The firm was established by Eldad Tamir and Dani Fishman. Eldad Tamir currently serves as CEO.

What are some of the sectors Tamir Fishman Ventures has invested in?

Tamir Fishman Ventures has invested in sectors such as Cyber Security, Industrial Technologies, Business Software, and Health Tech & Life Sciences.

Can you name a portfolio company in the Health Tech & Life Sciences sector?

VESSL Therapeutics is a portfolio company in the Health Tech & Life Sciences sector, which has raised $30 million in Seed funding.